These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1945607)

  • 21. [Detection of influenza B virus antibodies in different age groups using hemagglutination inhibition tests].
    Sonuvar S; Kocabeyoğlu O; Emekdaş
    Mikrobiyol Bul; 1991 Jan; 25(1):36-46. PubMed ID: 1881357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
    Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G
    Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP; Brown A; Valentijn RM; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2004 Jun; 22(17-18):2199-201. PubMed ID: 15149777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination.
    Vesikari T; Groth N; Karvonen A; Borkowski A; Pellegrini M
    Vaccine; 2009 Oct; 27(45):6291-5. PubMed ID: 19840662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.
    Engler RJ; Nelson MR; Klote MM; VanRaden MJ; Huang CY; Cox NJ; Klimov A; Keitel WA; Nichol KL; Carr WW; Treanor JJ;
    Arch Intern Med; 2008 Dec; 168(22):2405-14. PubMed ID: 19064822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.
    Keitel WA; Atmar RL; Nino D; Cate TR; Couch RB
    J Infect Dis; 2008 Oct; 198(7):1016-8. PubMed ID: 18729777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing appearance of reassortant influenza B virus in Taiwan from 2002 to 2005.
    Tsai HP; Wang HC; Kiang D; Huang SW; Kuo PH; Liu CC; Su IJ; Wang JR
    J Clin Microbiol; 2006 Aug; 44(8):2705-13. PubMed ID: 16891481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [DEVELOPMENT OF THE QUADRIVALENT LIVE ATTENUATED INFLUENZA VACCINE INCLUDING TWO INFLUENZA B LINEAGES--VICTORIA AND YAMAGATA].
    Desheva YA; Smolonogina TA; Doroshenko EM; Rudenko LG
    Vopr Virusol; 2016; 61(1):16-20. PubMed ID: 27145595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy.
    Tanzi E; Esposito S; Bojanin J; Amendola A; Trabattoni D; Pariani E; Pinzani R; Zanetti A; Principi N
    J Med Virol; 2006 Apr; 78(4):440-5. PubMed ID: 16482542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season].
    de Jong JC; Rimmelzwaan GF; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2007 Sep; 151(39):2158-65. PubMed ID: 17957994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the demographic and clinical characteristics of laboratory-confirmed influenza B Yamagata and Victoria lineage infection.
    Sočan M; Prosenc K; Učakar V; Berginc N
    J Clin Virol; 2014 Sep; 61(1):156-60. PubMed ID: 25034374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune response to inactivated influenza virus vaccine: antibody reactivity with epidemic influenza B viruses of two highly distinct evolutionary lineages.
    Pyhälä R; Kleemola M; Kumpulainen V; Vartiainen E; Lappi S; Pönkä A; Cantell K
    Vaccine; 1992; 10(9):631-6. PubMed ID: 1502842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine-mismatched influenza B/Yamagata lineage viruses in Cuba, 2012-2013 season.
    Arencibia A; Piñón A; Acosta B; Fernandez L; Muné M; Valdés O; Savón C; Oropesa S; Gonzalez G; Roque R; Gonzalez G; Hernández B; Alfonso JM
    Infect Genet Evol; 2018 Mar; 58():110-114. PubMed ID: 29229320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-reactive antibodies induced by a monovalent influenza B virus vaccine.
    Levandowski RA; Gross PA; Weksler M; Staton E; Williams MS; Bonelli J
    J Clin Microbiol; 1991 Jul; 29(7):1530-2. PubMed ID: 1885750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    Verma S; Soto J; Vasudevan A; Schmeisser F; Alvarado-Facundo E; Wang W; Weiss CD; Weir JP
    PLoS One; 2017; 12(4):e0175733. PubMed ID: 28423025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Virological characterization of influenza B virus in mainland China during 2011-2012].
    Huang WJ; Tan MJ; Lan Y; Cheng YH; Wang Z; Li XY; Guo JF; Wei HJ; Chen YY; Xiao N; Liu B; Sui HT; Zhao X; Wang DY; Shu YL
    Bing Du Xue Bao; 2013 Jan; 29(1):32-8. PubMed ID: 23547377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia.
    Porter CC; Edwards KM; Zhu Y; Frangoul H
    Pediatr Blood Cancer; 2004 Jan; 42(1):36-40. PubMed ID: 14752792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemagglutination-inhibiting antibodies against influenza A and B in human sera collected from five ecological zones in Nigeria.
    Olaleye DO; Baba SS; Omilabu SA; Fagbami AH
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(4):395-406. PubMed ID: 1804870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the case for trivalent or quadrivalent influenza vaccines.
    Baxter D
    Hum Vaccin Immunother; 2016 Oct; 12(10):2712-2717. PubMed ID: 27435025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people.
    Glathe H; Bigl S; Grosche A
    Vaccine; 1993; 11(7):702-5. PubMed ID: 8342318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.